← All trials
NCT02783833
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2016
- Primary completion
- Jan 16, 2017
- Completion date
- Jan 16, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Medicines for Malaria VentureLead sponsor
- Q-PharmOverall official - principal investigator
- University of QueenslandCollaborator
- Clinical Neuroscience Solutions, Inc.Collaborator
- Q-PharmCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.